Clinical Trial: Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433673) titled 'Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)' on Feb. 20.

Brief Summary: This study is being conducted to find out if treatment with gemcitabine, cisplatin, nab-paclitaxel, and cemiplimab can shrink previously inoperable tumors enough for surgery.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Colon and Rectal Cancer

Intervention: DRUG: Cemiplimab

intravenous 300mg

Recruitment Status: RECRUITING

Sponsor: Columbia University

Information provided by (Responsible Party): Linda Wu, Columbia University

Published by HT Digital Content Services wi...